Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hassan Alkhateeb

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
American Journal of Hematology|March 10, 2022
Mast cell sarcoma: 2 Mayo Clinic casesAmritpal Singh, Hassan Alkhateeb, Animesh Pardanani, et al.
Annals of the American Thoracic Society|December 15, 2020
Pretransplant Risk Factors Can Predict Development of Acute Respiratory Distress Syndrome after Hematopoietic Stem Cell TransplantationSvetlana Herasevich, Ryan D Frank, Hong Bo, et al.
Transplantation and Cellular Therapy|June 7, 2025
Malignancies after Chimeric Antigen Receptor T Cell TherapyRazan Mohty, Amal Halwani, Talha Badar, et al.
Respiratory Care|September 20, 2022
Post-Transplant and In-Hospital Risk Factors for ARDS After Hematopoietic Stem Cell TransplantationSvetlana Herasevich, Ryan D Frank, William J Hogan, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 17, 2014
Monosomal karyotype predicts adverse prognosis in patients diagnosed with chronic myelomonocytic leukemia: a single-institution experienceAysha Alsahlawi, Hassan Alkhateeb, Mrinal Patnaik, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|December 19, 2018
Hemolytic Uremic Syndrome Associated With <i>Escherichia coli</i> O157 Infection in an Allogenic Stem Cell Transplant RecipientJesus Vera-Aguilera, Narjust Duma, Kelly Gast, et al.
Blood Cancer Journal|February 16, 2023
CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive casesRimal Ilyas, Kristen McCullough, Talha Badar, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 17, 2021
Use of sublingual tacrolimus in adults undergoing hematopoietic cell transplant: A pilot studyHeather P May, Gabriel T Bartoo, Robert C Wolf, et al.
American Journal of Hematology|April 19, 2023
Sodium-glucose co-transporter-2 inhibitor use and JAK2 unmutated erythrocytosis in 100 consecutive casesNaseema Gangat, Mostafa Abdallah, Natasha Szuber, et al.
Leukemia Research|September 28, 2015
Prognostic impact of combined NPM1+/FLT3- genotype in patients with acute myeloid leukemia with intermediate risk cytogenetics stratified by age and treatment modalitiesMehrdad Hefazi, Mustaqeem Siddiqui, Mrinal Patnaik, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
American Journal of Hematology|March 10, 2022
Mast cell sarcoma: 2 Mayo Clinic casesAmritpal Singh, Hassan Alkhateeb, Animesh Pardanani, et al.
Annals of the American Thoracic Society|December 15, 2020
Pretransplant Risk Factors Can Predict Development of Acute Respiratory Distress Syndrome after Hematopoietic Stem Cell TransplantationSvetlana Herasevich, Ryan D Frank, Hong Bo, et al.
Transplantation and Cellular Therapy|June 7, 2025
Malignancies after Chimeric Antigen Receptor T Cell TherapyRazan Mohty, Amal Halwani, Talha Badar, et al.
Respiratory Care|September 20, 2022
Post-Transplant and In-Hospital Risk Factors for ARDS After Hematopoietic Stem Cell TransplantationSvetlana Herasevich, Ryan D Frank, William J Hogan, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 17, 2014
Monosomal karyotype predicts adverse prognosis in patients diagnosed with chronic myelomonocytic leukemia: a single-institution experienceAysha Alsahlawi, Hassan Alkhateeb, Mrinal Patnaik, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|December 19, 2018
Hemolytic Uremic Syndrome Associated With <i>Escherichia coli</i> O157 Infection in an Allogenic Stem Cell Transplant RecipientJesus Vera-Aguilera, Narjust Duma, Kelly Gast, et al.
Blood Cancer Journal|February 16, 2023
CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive casesRimal Ilyas, Kristen McCullough, Talha Badar, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 17, 2021
Use of sublingual tacrolimus in adults undergoing hematopoietic cell transplant: A pilot studyHeather P May, Gabriel T Bartoo, Robert C Wolf, et al.
American Journal of Hematology|April 19, 2023
Sodium-glucose co-transporter-2 inhibitor use and JAK2 unmutated erythrocytosis in 100 consecutive casesNaseema Gangat, Mostafa Abdallah, Natasha Szuber, et al.
Leukemia Research|September 28, 2015
Prognostic impact of combined NPM1+/FLT3- genotype in patients with acute myeloid leukemia with intermediate risk cytogenetics stratified by age and treatment modalitiesMehrdad Hefazi, Mustaqeem Siddiqui, Mrinal Patnaik, et al.
Pageof 9